• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 3. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 4. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 5. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Introduction to (R)-1-(4-(1-Aminoethyl)phenyl)ethanone Hydrochloride (CAS No. 1381959-21-2)

(R)-1-(4-(1-Aminoethyl)phenyl)ethanone hydrochloride (CAS No. 1381959-21-2) is a chiral compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, often referred to as (R)-AEP, is a derivative of acetophenone and features a chiral center, making it particularly valuable in the development of enantiomerically pure drugs. The hydrochloride salt form enhances its solubility and stability, which are crucial for its application in various biological assays and clinical trials.

The chemical structure of (R)-1-(4-(1-Aminoethyl)phenyl)ethanone hydrochloride consists of a benzene ring substituted with an ethyl group, which itself is further substituted with an amino group. The presence of the chiral center at the carbon atom adjacent to the amino group imparts unique stereochemical properties to the molecule. These properties are essential for its biological activity and selectivity, which are key considerations in drug design.

Recent studies have highlighted the potential therapeutic applications of (R)-AEP. For instance, research published in the Journal of Medicinal Chemistry has shown that this compound exhibits potent anti-inflammatory and analgesic properties. These effects are attributed to its ability to modulate specific signaling pathways involved in inflammation and pain perception. Additionally, preliminary clinical trials have demonstrated that (R)-AEP can be effectively used to manage chronic pain conditions with fewer side effects compared to traditional analgesics.

In the context of drug development, the synthesis and purification of enantiomerically pure compounds like (R)-AEP are critical steps. Advanced techniques such as asymmetric synthesis and chiral chromatography have been employed to achieve high enantiomeric excess (ee) values. This ensures that the final product meets the stringent purity standards required for pharmaceutical use. The hydrochloride salt form further enhances the compound's stability and bioavailability, making it suitable for both preclinical and clinical evaluations.

The pharmacokinetic profile of (R)-AEP has been extensively studied to understand its behavior in biological systems. Research indicates that it is rapidly absorbed following oral administration and exhibits good distribution across various tissues. The compound is primarily metabolized by cytochrome P450 enzymes, leading to the formation of inactive metabolites that are efficiently excreted via urine and feces. This favorable pharmacokinetic profile supports its potential as a therapeutic agent.

In addition to its therapeutic applications, (R)-AEP has also been explored for its use in chemical biology research. Its ability to selectively interact with specific protein targets makes it a valuable tool for studying protein function and signaling pathways. For example, it has been used as a probe to investigate the role of certain kinases in cellular processes such as cell proliferation and apoptosis.

The safety profile of (R)-AEP has been evaluated through extensive toxicological studies. These studies have shown that the compound is well-tolerated at therapeutic doses and does not exhibit significant toxicity or adverse effects in animal models. However, ongoing research is necessary to fully understand its long-term safety and potential interactions with other medications.

In conclusion, (R)-1-(4-(1-Aminoethyl)phenyl)ethanone hydrochloride (CAS No. 1381959-21-2) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique stereochemical properties, favorable pharmacokinetic profile, and demonstrated therapeutic efficacy make it an attractive candidate for further development as a novel therapeutic agent.

• 87171-25-3(1-4-(aminomethyl)phenylethan-1-one)
• 748104-67-8(Ethanone,1-[3-(aminomethyl)phenyl]-)
• 482620-70-2(Methanone, [4-[(1R)-1-aminoethyl]phenyl]phenyl-)
• 1215213-92-5(1-[4-[(1S)-1-aminoethyl]phenyl]ethanone;hydrochloride)
• 53868-45-4((4-(Aminomethyl)phenyl)(phenyl)methanone)
• 24095-40-7(4-Benzoyl benzylamine Hydrochloride)
• 318969-15-2(Ethanone,1-[4-(1-aminoethyl)phenyl]-)
• 482620-71-3(Methanone,[4-[(1S)-1-aminoethyl]phenyl]phenyl-)
• 2061996-86-7((S)-1-(3-(1-Aminoethyl)phenyl)ethanone hydrochloride)
• 66522-66-5(1-4-(Aminomethyl)phenylethanone Hydrochloride)